Can we predict the response to cyclosporine?

被引：0
|
作者：
del Val, J. Hinojosa [1 ]
Arce, N. Maroto [1 ]
机构：
[1] Hosp Sagunto, Unit Digest Dis, Valencia, Spain
来源：
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS | 2009年 / 101卷 / 03期
关键词：
SEVERE ULCERATIVE-COLITIS; INTRAVENOUS CYCLOSPORINE; SEVERE ATTACKS; THERAPY; INFLIXIMAB; REMISSION; PROGNOSIS;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：157 / 159
页数：3
相关论文
共 50 条
  • [31] Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
    Habashy, Hany Onsy
    Powe, Desmond G.
    Staka, Cindy M.
    Rakha, Emad A.
    Ball, Graham
    Green, Andrew R.
    Aleskandarany, Mohammed
    Paish, E. Claire
    Macmillan, R. Douglas
    Nicholson, Robert I.
    Ellis, Ian O.
    Gee, Julia M. W.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (02) : 283 - 293
  • [32] Oracle or false prophet? Can we predict AAV efficacy based on preexisting antibody titers?
    Anguela, Xavier M.
    High, Katherine A.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (02) : 149 - 151
  • [33] Clinical course of patients with aspirin-exacerbated respiratory disease: can we predict the prognosis?
    Kim, Joo-Hee
    Choi, Gil-Soon
    Kim, Jeong-Eun
    Jin, Hyun-Jung
    Ye, Young-Min
    Kim, Seung-Hyun
    Park, Hae-Sim
    PHARMACOGENOMICS, 2014, 15 (04) : 449 - 457
  • [34] Can we predict the need for pharmacological treatment according to demographic and clinical characteristics in gestational diabetes?
    Meshel, Shelly
    Schejter, Eduardo
    Harel, Tamar
    Maslovitz, Sharon
    Germez, Nurit
    Elimelech, Batya
    Cohen, Bili
    Azuri, Joseph
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (13): : 2062 - 2066
  • [35] Biologics for inflammatory bowel diseases in the Asia-Pacific: Can we afford to use them, can we afford not to?
    Gearry, Richard B.
    Irving, Peter M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (07) : 1160 - 1162
  • [36] Personalized medicine in rheumatic diseases: how close are we to being able to use genetic biomarkers to predict response to TNF inhibitors?
    Sutcliffe, Megan
    Radley, Gemma
    Barton, Anne
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (04) : 389 - 396
  • [37] When can we cure Crohn's?
    Mantzaris, Gerassimos J.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2014, 28 (03) : 519 - 529
  • [38] Prior to Initiation of Chemotherapy, Can We Predict Breast Tumor Response? Deep Learning Convolutional Neural Networks Approach Using a Breast MRI Tumor Dataset
    Ha, Richard
    Chin, Christine
    Karcich, Jenika
    Liu, Michael Z.
    Chang, Peter
    Mutasa, Simukayi
    Van Sant, Eduardo Pascual
    Wynn, Ralph T.
    Connolly, Eileen
    Jambawalikar, Sachin
    JOURNAL OF DIGITAL IMAGING, 2019, 32 (05) : 693 - 701
  • [39] CAN WE EQUATE ALL PROTON PUMP INHIBITORS WITH ONE ANOTHER? RESPONSE
    Hinson, Andrew M.
    Stack, Brendan C., Jr.
    Bodenner, Donald L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (05) : 1151 - 1151
  • [40] Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy
    Patel, Parita
    Yarur, Andres
    Dalal, Sushila
    Sakuraba, Atsuhi
    Rubin, David T.
    Hanauer, Stephen B.
    Hanan, Ira
    Raffals, Laura H.
    Cohen, Russell D.
    Pekow, Joel
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (06) : 1291 - 1297
12345